Surgery Partners Q1 2023 Earnings Report
Key Takeaways
Surgery Partners, Inc. reported an 11.7% increase in revenue to $666.2 million for the first quarter of 2023. The company's net loss attributable to Surgery Partners, Inc. was $24.9 million, with an adjusted EBITDA of $90.1 million. They are raising the outlook for 2023 Adjusted EBITDA to be greater than $430 million.
Revenue increased 11.7% from the prior year period to $666.2 million with same-facility revenue increasing 10.3%.
Net loss attributable to Surgery Partners, Inc. was $24.9 million.
Adjusted EBITDA of $90.1 million, 17% greater than the prior year period, with Adjusted EBITDA margin increased 60 basis points to 13.5%.
Raises outlook for 2023 Adjusted EBITDA to be greater than $430 million.
Surgery Partners
Surgery Partners
Surgery Partners Revenue by Segment
Forward Guidance
The Company raises projected 2023 Adjusted EBITDA to be greater than $430 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income